Pharming Group to participate in April investor conferences
Rhea-AI Summary
Pharming (Euronext: PHARM / Nasdaq: PHAR) announced management will participate in investor conferences in April 2026. Fabrice Chouraqui and Anurag Relan will present at the Needham Virtual Healthcare Conference on April 13, 2026 at 08:45 AM ET/14:45 CET. A live webcast and replay will be available in the company’s Upcoming Events and News sections.
Pharming will also attend the Van Lanschot Kempen Life Sciences Conference in Amsterdam on April 15, 2026. For one-on-one meeting requests, contact investor@pharming.com or your conference representative.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Market Pulse Summary
This announcement focused on Pharming’s participation in April investor conferences, including a Needham presentation on April 13, 2026 at 08:45 am ET and a Van Lanschot Kempen event on April 15, 2026. The key takeaway is increased investor access to management via webcasts and one-on-one meetings. Investors would monitor these events for any new clinical, commercial, or financial disclosures beyond what is stated in this scheduling update.
AI-generated analysis. Not financial advice.
Leiden, the Netherlands, April 7, 2026: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced that its management will participate in the following investor conferences in the month of April:
- 25th Annual Needham Virtual Healthcare Conference, April 13, 2026
Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, Chief Medical Officer, will present on Monday, April 13 at 08:45 am ET/14:45 CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website. - Van Lanschot Kempen Life Sciences Conference 2026, Amsterdam, NL, April 15, 2026
For more information about these conferences, or to schedule a one-on-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Needham or Van Lanschot Kempen representative.
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are developing and commercializing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with a significant proportion of its employees based in the U.S.
For more information, visit www.pharming.com and find us on LinkedIn.
For further public information, contact:
Investor Relations
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com
Media Relations
Global: Saskia Mehring, Corporate Communications Manager
T: +31 6 28 32 60 41
E: media.relations@pharming.com
U.S.: Ethan Metelenis (Precision AQ on behalf of Pharming)
T: +1 (917) 882-9038
Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming)
T: +31 6 53 81 64 27
Attachment